Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
From bystander to builder: government guidance will be essential for industry to thrive
Global political attention remains fixed on Washington. US president Donald Trump’s tariffs (and the circling threat of new tariffs) are challenging the global economic order and throwing governments into chaos. Intensifying economic…Accountability matters: Securing the future of devolution
English local government faces major reshaping.Nuclear enrichment: Building a stable and effective nuclear workforce
The government has talked a good game on the future of nuclear generation.